Pancreatic Cancer Research

ResearcherSecond Hospital of Tianjin Medical UniversityActive in the last 2 years

Hao Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-8187-0523; OpenAlex author ID A5045790705. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. lncRNA-based prognostic model for pancreatic cancer centered on the TME with exploratory LLPS connections. Co-author DOI 10.3389/fonc.2026.1753321↗
  2. Hypoxia- and lactate metabolism-associated prognostic and therapeutic signature in pancreatic cancer. Co-author DOI 10.1007/s12672-025-02873-w↗
  3. A prognostic model for anoikis-related genes in pancreatic cancer. Last author DOI 10.1038/s41598-024-65981-7↗
  4. Construction of a pancreatic cancer prediction model for oxidative stress-related lncRNA. Co-author DOI 10.1007/s10142-023-01048-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenhui Zhang · 2 shared papers, 2025–2026 · strength 0.62
  2. Hao Huang · 2 shared papers, 2023–2026 · strength 0.55
  3. Jinjin Sun · 2 shared papers, 2023–2025 · strength 0.54
  4. Yaqing Wei · 1 shared paper, 2026 · strength 0.32
  5. Wenbin Song · 1 shared paper, 2024 · strength 0.31
  6. Zhijia Jiang · 1 shared paper, 2025 · strength 0.30
  7. Ming Chen · 1 shared paper, 2023 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.